The Effect of Vitamin C on Pathological Parameters and Survival Duration of Critically Ill Coronavirus Disease 2019 Patients: A Randomized Clinical Trial
Nazanin Majidi, Faezeh Rabbani, Somayeh Gholami, Maryam Gholamalizadeh, Fatemeh Bourbour, Samira Rastgoo, Azadeh Hajipour, Mahdi Shadnoosh, Mohammad Esmail Akbari, Bojlul Bahar, Narjes Ashoori, Atiyeh Alizadeh, Forough Samipoor, Alireza Moslem, Saeid Doaei, Katsuhiko Suzuki
Frontiers in Immunology, doi:10.3389/fimmu.2021.717816
Conclusion: The present study demonstrated the potential of vitamin C supplementation in enhancing the survival duration of critically ill patients with COVID-19.
ETHICS STATEMENT The studies involving human participants were reviewed and approved by Ethical code: IR.MEDSAB.REC.1399.195. The patients/participants provided their written informed consent to participate in this study.
AUTHOR CONTRIBUTIONS NM, AH, SD, SG, SR, MG, FB, and NA designed the study and were involved in the data collection, analysis, and drafting of the manuscript. MA, BB, NA, AA, MSh, FS, AM, and KS were involved in the design of the study and analysis of the data and critically reviewed the manuscript. BB contributed to the data analysis and review of the manuscript. All authors contributed to the article and approved the submitted version.
FUNDING The funding for this study was provided by Sabzevar University of Medical Sciences, Sabzevar, Iran (code 99213).
Conflict of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Abu-Raya, Predictors of Refractory Coronavirus Disease (COVID-19) Pneumonia, Clin Infect Dis,
doi:10.1093/cid/ciaa409Ahnach, Zbiri, Nejjari, Ousti, Elkettani, C-Reactive Protein as an Early Predictor of COVID-19 Severity, J Med Biochem,
doi:10.5937/jomb0-27554Biancatelli, Berrill, Catravas, Marik, Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19), Front Immunol,
doi:10.3389/fimmu.2020.01451Bourbour, Dahka, Gholamalizadeh, Akbari, Shadnoush et al., Nutrients in Prevention, Treatment, and Management of Viral Infections; Special Focus on Coronavirus, Arch Physiol Biochem,
doi:10.1080/13813455.2020.1791188Cheng, Can Early and High Intravenous Dose of Vitamin C Prevent and Treat Coronavirus Disease 2019 (COVID-19)?, Med Drug Discov,
doi:10.1016/j.medidd.2020.100028Cosler, Tal, Strategy and Statistics in Clinical Trials: A non-Statisticians Guide to Thinking, Designing and Executing
Covid Cd, Team, Covid, Team, Zhang, Geographic Differences in COVID-19 Cases, Deaths, and Incidence-United States, Morbidity and Mortality Weekly Report
Earar, Arbune, Dorobat, Rusu-Negraia, Stefanescu et al., Biochemical Effects and Therapeutic Application of Vitamin C (C6H8O6) on COVID-19 Infection, Rev Chim,
doi:10.37358/RC.20.5.8159Fowler Aa3rd, Truwit, Hite, Morris, Dewilde et al., Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial, Jama,
doi:10.1001/jama.2019.11825Fujii, Luethi, Young, Frei, Eastwood et al., Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial, JAMA,
doi:10.1001/jama.2019.22176Hemilä, Chalker, Vitamin C can Shorten the Length of Stay in the ICU: A Meta-Analysis, Nutrients,
doi:10.3390/nu11040708Levine, Conry-Cantilena, Wang, Welch, Washko et al., Vitamin C Pharmacokinetics in Healthy Volunteers: Evidence for a Recommended Dietary Allowance, Proc Natl Acad Sci,
doi:10.1073/pnas.93.8.3704Liu, Zhang, Weng, Yang, Fan, Association Between Average Plasma Potassium Levels and 30-Day Mortality During Hospitalization in Patients With COVID-19 in Wuhan, China, Int J Med Sci,
doi:10.7150/ijms.50965Liu, Zhu, Zhang, Li, Peng, Intravenous High-Dose Vitamin C for the Treatment of Severe COVID-19: Study Protocol for a Multicentre Randomised Controlled Trial, BMJ Open,
doi:10.1136/bmjopen-2020-039519Lmasi-Hashiani, Doosti-Irani, Mansournia, Case Fatality Rate of COVID-19: Meta-Analysis Approach, Arch Iranian Med
Padayatty, Sun, Chen, Espey, Drisko et al., Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects, PloS One,
doi:10.1371/journal.pone.0011414Patterson, Cm, Fulzele, Low Level of Vitamin C and Dysregulation of Vitamin C Transporter Might be Involved in the Severity of COVID-19
Zhang, Rao, Li, Zhu, Liu et al., High-Dose Vitamin C Infusion for the Treatment of Critically Ill COVID-19, Ann Intensive Care,
doi:10.1186/s13613-020-00792-3Zou, Dai, Zhang, Zhang, Zhang, Hydroxychloroquine and Chloroquine: A Potential and Controversial Treatment for COVID-19, Arch Pharm Res,
doi:10.1007/s12272-020-01258-7
